Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Proteasome02:18

The Proteasome

8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
Regulated Protein Degradation02:58

Regulated Protein Degradation

7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome Structure01:17

The Proteasome Structure

708
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
708
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

12.1K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
12.1K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

5.5K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The atypical E3 ligase HOIL-1 safeguards the ribosome during cellular stress.

Nature cell biology·2026
Same author

Correction: Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation.

RSC chemical biology·2026
Same author

Quantitative Degradation Rate Assessment of bioPROTACs Based on Peptide Degrons, E3 Domains, Adapters and Conjugated Small Molecules.

ACS chemical biology·2026
Same author

Structure-guided design of a methyltransferase-like 3 (METTL3) proteolysis targeting chimera (PROTAC) incorporating an indole-nicotinamide chemotype.

RSC medicinal chemistry·2025
Same author

Design and Application of Cereblon-Recruiting Prodegraders.

Journal of the American Chemical Society·2025
Same author

An atypical E3 ligase safeguards the ribosome during nutrient stress.

bioRxiv : the preprint server for biology·2024

相关实验视频

Updated: Jun 8, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.5K

针对目标蛋白质降解的下一步.

Mackenzie W Krone1, Craig M Crews2

  • 1Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA.

Cell chemical biology
|November 5, 2024
PubMed
概括

向蛋白质降解 (TPD) 是一个有前途的治疗策略,新的分子降解剂接近临床批准. 为了扩大其医疗应用,需要在TPD平台,合成和复杂优化方面取得进一步的进步.

科学领域:

  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.
  • 药用化学 医学化学

背景情况:

  • 在过去的二十年中,有针对性的蛋白质降解 (TPD) 已成为一种强大的治疗策略.
  • 调节生物分子邻近性的化学方法比传统的蛋白质抑制具有优势,可以准以前无法治疗的与疾病相关的蛋白质.

研究的目的:

  • 突出TPD领域未来增长的关键领域.
  • 确定开发下一代分子降解剂的战略.
  • 要强调TPD在扩大治疗应用中的潜力.

主要方法:

  • 审查和综合TPD当前的进展.
  • 确定需要进一步研究和开发的关键领域.
  • 专注于时空精度,合成吞吐量和复杂的合作性.

主要成果:

  • 对于针对无法药物治疗的蛋白质,TPD提供了药理上的优势.
  • 临床前成功和现有的临床疗法证明了TPD的潜力.
  • 已经确定了扩大TPD工具箱的三个优先领域.

结论:

  • 在TPD平台,合成和诱导蛋白质复合体优化的持续创新至关重要.

更多相关视频

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.3K
Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae
09:05

Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae

Published on: April 18, 2016

28.9K

相关实验视频

Last Updated: Jun 8, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.5K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.3K
Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae
09:05

Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae

Published on: April 18, 2016

28.9K
  • 这些领域的进展将扩大近距离诱导药理学的治疗应用.
  • 医学中TPD的未来是有希望的,具有显著临床影响的潜力.